SCHEMBL8577441

SCHEMBL8577441

CC(=O)Nc1ccc2cc(NC(C)=O)ccc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.68
KMT2A Q03164 6/20 0.68
KDM4E B2RXH2 4/20 0.68
MAPT P10636 3/20 0.68
RAB9A P51151 3/20 0.68
NPC1 O15118 2/20 0.68
GLA P06280 1/20 0.68
TNNI3 P19429 1/20 0.68
TNNT2 P45379 1/20 0.68
TNNC1 P63316 1/20 0.68
RUNX1 Q01196 1/20 0.68
CBFB Q13951 1/20 0.68
SMN1; SMN2 Q16637 3/20 0.60
HTT P42858 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
PABPC1 P11940 1/20 0.58
ALDH1A1 P00352 5/20 0.58
TDP1 Q9NUW8 1/20 0.58
CA12 O43570 1/20 0.58
BRD4 O60885 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8576078 0.93 MEN1 (0.66) MEN1KMT2AKDM4EMAPTRAB9A
SCHEMBL1176635 0.92 MEN1 (0.69) MEN1KMT2AKDM4EMAPTRAB9A
SCHEMBL17919672 0.90 TDP1 (0.64) MEN1KMT2AKDM4EMAPTRAB9A
SCHEMBL1808467 0.90 MEN1 (0.64) MEN1KMT2AKDM4EMAPTRAB9A
Anthracene SCHEMBL29076817 0.90 MEN1 (0.67) MEN1KMT2AKDM4EMAPTRAB9A
SCHEMBL8549110 0.90 RAB9A (0.62) MEN1KMT2AKDM4EMAPTRAB9A
SCHEMBL1808465 0.90 MEN1 (0.58) MEN1KMT2AKDM4EMAPTRAB9A
SCHEMBL22815990 0.88 MEN1 (0.56) MEN1KMT2AKDM4EMAPTRAB9A
SCHEMBL12298751 0.88 MEN1 (0.56) MEN1KMT2AKDM4EMAPTRAB9A
SCHEMBL21765699 0.87 RAB9A (0.72) MEN1KMT2AKDM4EMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998014501-A1 PROCESS FOR THE PREPARATION OF THERMOTROPIC AROMATIC POLYESTERS DIRECTLY FROM DIALKYL AROMATIC ESTERS HOECHST CELANESE CORPORATION (US) 1998-04-09 WO claimed
US-5731401-A ONE STEP; HIGH MOLECULAR WEIGHT HOECHST CELANESE CORP. (US) 1998-03-24 US claimed
US-4883915-A TO AMIDES, BOROSILICATE MOLECULAR SIEVE AMOCO CORPORATION (US) 1989-11-28 US claimed
US-7803804-B2 Substituted pyrazines for use in the treatment of inflammatory or allergic conditions NOVARTIS AG (CH) 2010-09-28 US disclosed
US-7803804-B2 Substituted pyrazines for use in the treatment of inflammatory or allergic conditions NOVARTIS AG (CH) 2010-09-28 US disclosed
US-20080312217-A1 Organic Compounds NOVARTIS AG 2008-12-18 US disclosed
US-20080312217-A1 Organic Compounds NOVARTIS AG 2008-12-18 US disclosed
WO-1998014501-A1 PROCESS FOR THE PREPARATION OF THERMOTROPIC AROMATIC POLYESTERS DIRECTLY FROM DIALKYL AROMATIC ESTERS HOECHST CELANESE CORPORATION (US) 1998-04-09 WO disclosed
US-5731401-A ONE STEP; HIGH MOLECULAR WEIGHT HOECHST CELANESE CORP. (US) 1998-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312217-A1 Organic Compounds TRPA1, TRPV1, CHRM1 MEN1 1118/4885KMT2A 3363/4885KDM4E 4641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.